Invesco Ltd.

Position in OVID — Ovid Therapeutics Inc.

CIK 914208 Atlanta, GA

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$470,479

+$244,970 QoQ

Shares Held

174,900

+72.2% QoQ

Ownership

0.090%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 131 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 0% Shared 98% None 2%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. OVID ranks #190 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$470,479	174,900	+72.2%	Shares	Defined	2026-08-14
2026-03-31	$225,509	101,581	+205.0%	Shares	Defined	2026-05-12
2025-12-31	$54,292	33,308	+22.4%	Shares	Defined	2026-02-19
2025-03-31	$8,488	27,207	0.0%	Shares	Defined	2025-05-12
2024-12-31	$25,410	27,207	-7.3%	Shares	Defined	2025-02-13
2024-09-30	$34,616	29,337	+1.7%	Shares	Defined	2024-11-12
2024-06-30	$22,184	28,850	-2.4%	Shares	Defined	2024-08-13
2024-03-31	$90,138	29,554	-1.1%	Shares	Defined	2024-05-14
2023-12-31	$96,229	29,885	+30.0%	Shares	Defined	2024-02-13
2023-09-30	$88,269	22,987	0.0%	Shares	Defined	2023-11-13
2023-06-30	$75,396	22,987	+104.3%	Shares	Defined	2023-08-11
2021-03-31	$45,241	11,254	-98.3%	Shares	Defined	2021-05-17
2020-06-30	$4,981,382	675,900	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.